Beta Bionics, Inc. (BBNX) NASDAQ

17.00

+0.24(+1.43%)

Updated at July 31 03:34PM

Currency In USD

Valuation

Market Cap150.41M
Enterprise Value127.23M
P/E Ratio-10.05
PEG Ratio5.41
Price/Sales Ratio9.47
Price/Book Ratio2.45
Enterprise/Revenue9.11
Enterprise/EBITDA-10.74

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.94
Operating Margin-0.8

Management Effectiveness

Return On Assets-0.22
Return On Equity-0.41

Income Statement

Revenue65.12M
Revenue/Share1.8
Gross Profit35.89M
EBITDA-44.1M
Net Income-54.76M
Diluted EPS-8.6

Balance Sheet

Total Cash249.72M
Total Cash/Share5.76
Total Debt6.69M
Total Debt/Equity0.02
Current Ratio14.68
Book Value Per Share6.95

Price History

52-Week Change-28.06
52-Week High24.5
52-Week Low8.89
Moving Average 50 Days15.7
Moving Average 200 Days15.62

Statistics

Average Volume538,908
Shares Outstanding43.36M
% Held by Institutions136.18

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A